-
- Guido Arcaro
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Anna Cretti
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Sara Balzano
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Alessandro Lechi
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Michele Muggeo
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Enzo Bonora
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
-
- Riccardo C. Bonadonna
- From the Division of Endocrinology and Metabolic Diseases (A.C., S.B., M.M., E.B., R.C.B.) and Division of Internal Medicine (G.A., A.L.), Department of Biomedical and Surgical Sciences, University of Verona Medical School and Azienda Ospedaliera di Verona, Verona, Italy.
書誌事項
- タイトル別名
-
- Sites and Mechanisms
- 公開日
- 2002-02-05
- DOI
-
- 10.1161/hc0502.103333
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
説明
<jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Background</jats:italic> </jats:bold> — </jats:italic> </jats:bold> Insulin resistance is often accompanied by hyperinsulinemia and may predispose to atherosclerosis. Endothelium plays a central role in atherogenesis. The in vivo effects of hyperinsulinemia on endothelial function of large conduit arteries are unknown. </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Methods and Results</jats:italic> </jats:bold> — </jats:italic> </jats:bold> Twenty-five healthy subjects were enrolled for study. In study A (n=9), subjects underwent both a time-control saline study and a euglycemic low-dose insulin (insulin ≈110 pmol/L) clamp for 6 hours. Study B (n=5) was identical to study A except that the euglycemic clamp was performed at high physiological insulin concentrations (≈440 pmol/L). In study C (n=7), subjects underwent two 4-hour euglycemic insulin (≈110 pmol/L) clamps with and without the concomitant infusion of an antioxidant (vitamin C). In study D (n=4), two saline time-control studies were performed with and without the concomitant infusion of vitamin C. In all studies, both at baseline and throughout the experimental period, endothelium-dependent (flow-mediated) and endothelium-independent (nitroglycerin-induced) vasodilation was assessed in femoral and brachial arteries by echo Doppler. Both low (study A) and high physiological (study B) hyperinsulinemia abolished endothelium-dependent vasodilation, whereas endothelium-independent vasodilation was unaffected. Vitamin C fully restored insulin-impaired endothelial function without affecting endothelium-independent vasodilation (study C). Vitamin C had no effects on endothelium-dependent or endothelium-independent vasodilation during saline control studies (study D). </jats:p> <jats:p> <jats:bold> <jats:italic> <jats:bold> <jats:italic>Conclusions</jats:italic> </jats:bold> — </jats:italic> </jats:bold> Modest hyperinsulinemia, mimicking fasting hyperinsulinemia of insulin-resistant states, abrogates endothelium-dependent vasodilation in large conduit arteries, probably by increasing oxidant stress. These data may provide a novel pathophysiological basis to the epidemiological link between hyperinsulinemia/insulin-resistance and atherosclerosis in humans. </jats:p>
収録刊行物
-
- Circulation
-
Circulation 105 (5), 576-582, 2002-02-05
Ovid Technologies (Wolters Kluwer Health)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1362825895197494016
-
- NII論文ID
- 30022666932
-
- ISSN
- 15244539
- 00097322
-
- データソース種別
-
- Crossref
- CiNii Articles